Found review: pricing, fine print, and how it ranks

The price, in words

On tirzepatide, Found prices out at $289 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $169/mo (12-month plan paid up front). That ranks #5 of 17 priced compounded programs — $74 a month above the field's floor (NexLife at $215). Semaglutide runs $289 a month all-in at the standing rate ($169 on intro/plan terms). (#14 of 19 on our semaglutide basis)

What the fine print says

The $169/mo figure requires paying the 12-month plan paid up front up front; in a contested regulatory environment, read the refund terms before locking a year into any compounded program. The lowest advertised rate is a twelve-month plan paid up front. Month-to-month costs substantially more ($289), so the gap between the headline and the flexible rate is one of the widest we track.

Pharmacy & transparency

Price evidence: Third-party-reported, last verified 2026-08-05. The dispensing pharmacy is not named publicly — the single most common transparency gap in this market. Ask which pharmacy fills the prescription, whether it is 503A or 503B, and whether a certificate of analysis is available; our pharmacy guide explains what each answer means.

The dose ladder, priced rung by rung

Walk Found's ladder and the price never moves: every rung from 2.5 to 15 mg bills the same $289, which turns titration from a budgeting exercise into a clinical one. The practical consequences compound over a treatment course: the standard four-month climb to 10 mg costs exactly $1,156 (four flat months, no arithmetic), a post-plateau escalation from 10 to 12.5 mg is clinically free, and holding a dose an extra month for tolerability — the standard side-effect play — changes nothing on the bill. Against dose-scaled competitors whose entry figures climb 40–75% by maintenance, and against Zepbound's $299→$449 steps, a flat ladder means the advertised number is the number you keep paying.

What the first year actually bills

The annual number — the honest one — is $3,468 for year one on Found's standing plan: twelve identical charges of $289, titration included, because the flat structure makes month one and month twelve the same line item. Prepay and the effective rate drops to $169/month (12-month plan paid up front), an annualized $2,028 — a real $1,440 saving against the standing year, purchased with locked funds whose refund terms deserve a read in a contested regulatory year. Benchmarked to the verified floor, the year costs $888 more than NexLife's $2,580 — the premium a buyer should be able to name a reason for. Brand context: Zepbound's comparable first year via LillyDirect runs about $5,188 on a standard titration, and $5,388 for a full year already at maintenance.

The 24-month view

Because this class works while taken, the two-year number deserves the spotlight: Found at standing rates bills $6,936 across 24 months, against $4,056 if the prepaid rate could be held for both years ($2,880 of committed-money savings). The same 24 months cost $5,160 at the verified floor and $10,776 on brand Zepbound at maintenance — bookends worth writing on the first invoice.

The semaglutide side of the house

Found prices semaglutide at $289/month all-in at the standing rate, ranking #14 of 19 on our verified semaglutide basis — against a field floor of $133 (Oak Longevity, with state limits) and brand Wegovy's flat $349. Plan detail worth reading before checkout: $169/mo on a 12-month plan paid up front with medication included flat at all doses (tirzepatide is no longer priced above semaglutide on the prepaid plan); about $199/mo on 6-month terms; $289 month-to-month. The in-house premium for stepping up to tirzepatide is $0/month — the local price of SURMOUNT-5's 20.2%-vs-13.7% head-to-head result, and a switch that stays inside one program's intake and pharmacy relationships.

Where it sits in the market

On the verified tirzepatide board, Found's $289 all-in rate ranks #5 of 17: $74/month above the NexLife floor; one rung cheaper sits Mochi Health at $278 (a $11/mo gap); one rung pricier is ShedRx at $289. Against the FDA-approved benchmark, the same year costs $1,920 less than Zepbound's $449 maintenance tier — the discount a buyer is accepting compounded-product risk to collect. The full board, sortable and dated, is the tirzepatide ranking.

Three buyers, priced honestly

The week-one starter. First month at the 2.5 mg rung: $289 — same as every later month on the flat plan. The 10 mg maintainer. Settled at maintenance, the run-rate is $289/month, $3,468/year — the figure that should anchor any comparison, since it describes years two and three, not the promo. The prepay optimizer. Committing to the 12-month plan paid up front cuts the effective rate to $169/month ($2,028/yr) — cheapest path here, least flexible money, refund terms first.

Nearest alternatives at this price point

Price-band neighbors worth a look before deciding: ShedRx at $289 (no membership); OrderlyMeds at $299 (flat at every dose, no membership); SkinnyRx at $299 (flat at every dose, no membership) — each linked matchup runs the full head-to-head arithmetic on this exact question.

State availability

Found publishes availability of: most states. State-by-state context, exceptions, and city coverage live in the 51-state cost guides.

Five questions before checkout

Whatever the marketing says, get answers to: (1) the all-in monthly price at 10 mg and at 12.5 mg, in writing, including every mandatory fee; (2) which pharmacy, by name, fills the prescription — and whether it's 503A or 503B, licensed for your state, with a certificate of analysis available; (3) the refund terms on the prepaid plan, verbatim, before any multi-month charge; (4) the cancellation mechanics — deadline relative to renewal, written-confirmation availability, and whether any membership cancels separately. A program that answers all five plainly has already told you most of what this review can.

Visit Found — verify current pricing →Opens the provider’s own pricing page; our figures were captured 2026-08-05.

Bottom line

Found sits mid-pack on tirzepatide price. For context, the verified market floor is $215/mo compounded tirzepatide and $133/mo compounded semaglutide, with brand Zepbound at $449/mo and Wegovy at $349/mo at maintenance.